Li Q - Search Results

1

The Efficacy of Synchronous Combination of Chemotherapy and EGFR TKIs for the First-Line Treatment of NSCLC: A Systematic Analysis.

Yan H, Li H, Li Q, Zhao P, Wang W, Cao B. Yan H, et al. Among authors: li h, li q. PLoS One. 2015 Aug 18;10(8):e0135829. doi: 10.1371/journal.pone.0135829. eCollection 2015. PLoS One. 2015. PMID: 26285137 Free PMC article. Review.

2

Efficacy and safety of gemcitabine-fluorouracil combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomized controlled trials.

Li Q, Yan H, Liu W, Zhen H, Yang Y, Cao B. Li Q, et al. PLoS One. 2014 Aug 5;9(8):e104346. doi: 10.1371/journal.pone.0104346. eCollection 2014. PLoS One. 2014. PMID: 25093849 Free PMC article.

3

Systems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patients.

Yan H, Li Q, Wang W, Zhen H, Cao B. Yan H, et al. Among authors: li q. Sci Rep. 2015 Oct 20;5:15355. doi: 10.1038/srep15355. Sci Rep. 2015. PMID: 26481697 Free PMC article.

4

Efficacy and Safety of Bevacizumab Combined with Chemotherapy for Managing Metastatic Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.

Li Q, Yan H, Zhao P, Yang Y, Cao B. Li Q, et al. Sci Rep. 2015 Oct 27;5:15746. doi: 10.1038/srep15746. Sci Rep. 2015. PMID: 26503902 Free PMC article.

5

Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy.

Zhao P, Li L, Jiang X, Li Q. Zhao P, et al. Among authors: li l, li q. J Hematol Oncol. 2019 May 31;12(1):54. doi: 10.1186/s13045-019-0738-1. J Hematol Oncol. 2019. PMID: 31151482 Free PMC article. Review.

6

The function of human epidermal growth factor receptor-3 and its role in tumors (Review).

Li Q, Yuan Z, Cao B. Li Q, et al. Oncol Rep. 2013 Dec;30(6):2563-70. doi: 10.3892/or.2013.2754. Epub 2013 Sep 30. Oncol Rep. 2013. PMID: 24084886

7

Comparison of gemcitabine combined with targeted agent therapy versus gemcitabine monotherapy in the management of advanced pancreatic cancer.

Li Q, Yuan Z, Yan H, Wen Z, Zhang R, Cao B. Li Q, et al. Clin Ther. 2014 Jul 1;36(7):1054-63. doi: 10.1016/j.clinthera.2014.05.066. Epub 2014 Jun 27. Clin Ther. 2014. PMID: 24986485 Review.

8

Addition of docosahexaenoic acid synergistically enhances the efficacy of apatinib for triple-negative breast cancer therapy.

Ma Y, Yu J, Li Q, Su Q, Cao B. Ma Y, et al. Among authors: li q. Biosci Biotechnol Biochem. 2020 Apr;84(4):743-756. doi: 10.1080/09168451.2019.1709789. Epub 2019 Dec 31. Biosci Biotechnol Biochem. 2020. PMID: 31889475

9

The Effect of Omega-3 Polyunsaturated Fatty Acid Supplementations on anti-Tumor Drugs in Triple Negative Breast Cancer.

Ma Y, Wang J, Li Q, Cao B. Ma Y, et al. Among authors: li q. Nutr Cancer. 2021;73(2):196-205. doi: 10.1080/01635581.2020.1743873. Epub 2020 Mar 30. Nutr Cancer. 2021. PMID: 32223441 Review.

10

Characteristics and prognostic values of traditional pathological parameters and advanced molecular subtypes in women in Beijing with operable breast cancer: a retrospective analysis.

Li Q, Li L, Jiang X, Du Q, Li Y, Li T, Gong H, Cao B. Li Q, et al. Among authors: li t, li y, li l. BMJ Open. 2018 Nov 8;8(11):e021819. doi: 10.1136/bmjopen-2018-021819. BMJ Open. 2018. PMID: 30413499 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65,757 results

Search Page

Filters